| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |